The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Nijwening, Jeroen H ^a   Geutjes, Ernst Jan ^a   Bernards, Rene ^a   Beijersbergen, Roderick L ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; JARID1B PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; KDM5B PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL AGING; CELL CYCLE ARREST; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; EMBRYO CELL; ENZYME ACTIVITY; FIBROBLAST; GENE TARGETING; GENETIC SCREENING; NONHUMAN; PROTEIN DEPLETION; PROTEIN FUNCTION; CELL CULTURE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; GENETICS; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MURINAE;

BLOTTING, WESTERN; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; FIBROBLASTS; IMMUNOPRECIPITATION; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 80053203114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025235     Document Type: Article

References (54)

1. Campisi J, d'Adda di Fagagna F, (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
2. Prieur A, Peeper DS, (2008) Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 20: 150-155.
3. Adams PD, (2007) Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397: 84-93.
4. Courtois-Cox S, Jones SL, Cichowski K, (2008) Many roads lead to oncogene-induced senescence. Oncogene 27: 2801-2809.
5. Macaluso M, Montanari M, Giordano A, (2006) Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes. Oncogene 25: 5263-5267.
6. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, et al. (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21: 525-530.
7. Dietrich N, Bracken AP, Trinh E, Schjerling CK, Koseki H, et al. (2007) Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J 26: 1637-1648.
8. Pasini D, Hansen KH, Christensen J, Agger K, Cloos PA, et al. (2008) Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev 22: 1345-1355.
9. Tzatsos A, Pfau R, Kampranis SC, Tsichlis PN, (2009) Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus. Proc Natl Acad Sci U S A 106: 2641-2646.
10. Pfau R, Tzatsos A, Kampranis SC, Serebrennikova OB, Bear SE, et al. (2008) Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad Sci U S A 105: 1907-1912.
11. Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, et al. (2009) The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev 23: 1171-1176.
12. Barradas M, Anderton E, Acosta JC, Li S, Banito A, et al. (2009) Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev 23: 1177-1182.
13. Narita M, Nunez S, Heard E, Lin AW, Hearn SA, et al. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716.
14. Ferreira R, Naguibneva I, Pritchard LL, Ait-Si-Ali S, Harel-Bellan A, (2001) The Rb/chromatin connection and epigenetic control: opinion. Oncogene 20: 3128-3133.
15. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS, (2010) The essence of senescence. Genes Dev 24: 2463-2479.
16. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, et al. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665.
17. Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, et al. (2010) Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17: 376-387.
18. Talluri S, Isaac CE, Ahmad M, Henley SA, Francis SM, et al. (2010) A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol Cell Biol 30: 948-960.
19. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, et al. (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9: 2799-2809.
20. Brummelkamp TR, Kortlever RM, Lingbeek M, Trettel F, MacDonald ME, et al. (2002) TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J Biol Chem 277: 6567-6572.
21. Dirac AM, Bernards R, (2003) Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J Biol Chem 278: 11731-11734.
22. Epping MT, Meijer LA, Krijgsman O, Bos JL, Pandolfi PP, et al. (2011) TSPYL5 suppresses p53 levels and function by physical interaction with USP7. Nat Cell Biol 13: 102-108.
23. Shi Y, Whetstine JR, (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 25: 1-14.
24. Kouzarides T, (2007) Chromatin modifications and their function. Cell 128: 693-705.
25. Vogt T, Kroiss M, McClelland M, Gruss C, Becker B, et al. (1999) Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer. Lab Invest 79: 1615-1627.
26. Lu PJ, Sundquist K, Baeckstrom D, Poulsom R, Hanby A, et al. (1999) A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem 274: 15633-15645.
27. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, et al. (2007) RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128: 1063-1076.
28. Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, et al. (2007) The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128: 1077-1088.
29. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, et al. (2007) The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128: 889-900.
30. Seward DJ, Cubberley G, Kim S, Schonewald M, Zhang L, et al. (2007) Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat Struct Mol Biol 14: 240-242.
31. Xiang Y, Zhu Z, Han G, Ye X, Xu B, et al. (2007) JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci U S A 104: 19226-19231.
32. Cloos PA, Christensen J, Agger K, Helin K, (2008) Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev 22: 1115-1140.
33. Echeverri CJ, Beachy PA, Baum B, Boutros M, Buchholz F, et al. (2006) Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods 3: 777-779.
34. Roesch A, Becker B, Meyer S, Wild P, Hafner C, et al. (2005) Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod Pathol 18: 1249-1257.
35. Dannenberg JH, van Rossum A, Schuijff L, te Riele H, (2000) Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14: 3051-3064.
36. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, et al. (2000) Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14: 3037-3050.
37. Dannenberg JH, Schuijff L, Dekker M, van der Valk M, te Riele H, (2004) Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 18: 2952-2962.
38. Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, et al. (2006) A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126: 503-514.
39. Bandyopadhyay D, Curry JL, Lin Q, Richards HW, Chen D, et al. (2007) Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell 6: 577-591.
40. Scibetta AG, Santangelo S, Coleman J, Hall D, Chaplin T, et al. (2007) Functional analysis of the transcription repressor PLU-1/JARID1B. Mol Cell Biol 27: 7220-7235.
41. Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, et al. (2007) PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 25: 801-812.
42. Ruthenburg AJ, Allis CD, Wysocka J, (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25: 15-30.
43. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560.
44. Burkhart DL, Sage J, (2008) Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8: 671-682.
45. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW, (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
46. Tan K, Shaw AL, Madsen B, Jensen K, Taylor-Papadimitriou J, et al. (2003) Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9. J Biol Chem 278: 20507-20513.
47. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, et al. (2010) A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141: 583-594.
48. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
49. Halaban R, (2005) Rb/E2F: a two-edged sword in the melanocytic system. Cancer Metastasis Rev 24: 339-356.
50. Roesch A, Becker B, Schneider-Brachert W, Hagen I, Landthaler M, et al. (2006) Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells. J Invest Dermatol 126: 1850-1859.
51. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, et al. (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428: 431-437.
52. Huang S, Laoukili J, Epping MT, Koster J, Holzel M, et al. (2009) ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell 15: 328-340.
53. Blais A, van Oevelen CJ, Margueron R, Acosta-Alvear D, Dynlacht BD, (2007) Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. J Cell Biol 179: 1399-1412.
54. Rowland BD, Denissov SG, Douma S, Stunnenberg HG, Bernards R, et al. (2002) E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest. Cancer Cell 2: 55-65.